Diabetes care product company ARKRAY USA Inc reported on Monday the launch of newest blood glucose monitoring system (BGMS) in the US, the GLUCOCARD Shine XL.
According to the company, the GLUCOCARD Shine XL blood glucose monitoring system is now available for order in the US.
Highly accurate with a large LED screen intended to facilitate quick and easy viewing of blood glucose test results, the GLUCOCARD Shine XL BGMS offers an ergonomically designed meter that provides a secure grip during testing as well as uses the same test strips as the prior GLUCOCARD Shine, which has been proven to provide highly accurate test results in an easy to use form.
ARKRAY USA Inc, which is a division of ARKRAY headquartered in Kyoto, Japan, currently does business in more than 80 countries worldwide and is the market leader in diabetes management in the long-term care market in the US.
Diamyd Medical granted US FDA Fast Track designation for Diamyd diabetes treatment
Aprecia names new chief commercial officer
Insulet's Omnipod 5 integration with Abbott FreeStyle Libre 2 Plus Sensor secures CE Mark approval
Kyowa Kirin enrols first subject in phase two tivozanib eye drops (KHK4951) clinical trial
Novo Nordisk to boost manufacturing capacity with acquisition of three fill-finish sites
Breye Therapeutics commences phase 1b/2a danegaptide clinical trial
DexCom Inc breaks ground on new manufacturing facility in Ireland
VibroSense Dynamics AB secures provisional patent for chemotherapy-induced nerve damage prediction
Innovent Biologics signs collaboration agreement with Sanegene Bio USA
Japan approves GSK's filing for Arexvy vaccination for at-risk adults
Arecor Therapeutics plc extends collaboration with Eli Lilly
OptiBiotix Health partners with Ravenswood for SlimBiome distribution in Australia and New Zealand
Boehringer Ingelheim granted European approval of oral liquid medication for feline diabetes